Right drug, right patient, right time: aspiration or future promise for biologics in rheumatoid arthritis?
Author:
Publisher
Springer Science and Business Media LLC
Link
http://link.springer.com/content/pdf/10.1186/s13075-017-1445-3.pdf
Reference155 articles.
1. Nam JL, Winthrop KL, van Vollenhoven RF, Pavelka K, Valesini G, Hensor EM, et al. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA. Ann Rheum Dis. 2010;69:976–86.
2. van Nies JAB, de Jong Z, van der Helm-van Mil AHM, Knevel R, Le Cessie S, Huizinga TWJ. Improved treatment strategies reduce the increased mortality risk in early RA patients. Rheumatology. 2010;49:2210–6.
3. Joensuu JT, Huoponen S, Aaltonen KJ, Konttinen YT, Nordström D, Blom M. The cost-effectiveness of biologics for the treatment of rheumatoid arthritis: a systematic review. PLoS One. 2015;10:1–27.
4. Firestein GS. The disease formerly known as rheumatoid arthritis. Arthritis Res Ther. 2014;16:114.
5. Gibson DS, Bustard MJ, McGeough CM, Murray HA, Crockard MA, McDowell A, et al. Current and future trends in biomarker discovery and development of companion diagnostics for arthritis. Expert Rev Mol Diagn. 2015;15:219–34.
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Inappropriate treatment response to DMARDs: A pathway to difficult-to-treat rheumatoid arthritis;International Immunopharmacology;2023-09
2. Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry;Rheumatology and Therapy;2023-06-22
3. Molecular mechanisms of the development of the phenomena of peripheral and central sensitization in rheumatoid arthritis;Rheumatology Science and Practice;2023-03-03
4. Is Tofacitinib Effectiveness in Patients with Rheumatoid Arthritis Better After Conventional Than After Biological Therapy? – A Cohort Study in a Colombian Population;Biologics: Targets and Therapy;2022-07
5. Relationship of cytokine level dynamics with longterm results of early rheumatoid arthritis therapy;Rheumatology Science and Practice;2022-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3